往期推荐1默克与恒瑞制药就下一代选择性PARP1抑制剂和抗体药物偶联物达成战略合作 持续丰富肿瘤产品管线往期推荐2默克集团宣布与恒瑞医药再度达成合作,推进辅助生殖领域口服GnRH拮抗剂的商业化落地点击“阅读原文”立即报名
Source Link往期推荐1默克与恒瑞制药就下一代选择性PARP1抑制剂和抗体药物偶联物达成战略合作 持续丰富肿瘤产品管线往期推荐2默克集团宣布与恒瑞医药再度达成合作,推进辅助生殖领域口服GnRH拮抗剂的商业化落地点击“阅读原文”立即报名
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.